Zura Bio, a clinical-stage immunology company specializing in dual-pathway antibodies for autoimmune and inflammatory diseases, has announced the commencement of an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”). These initiatives pertain to its outstanding IPO warrants, which…
The World Health Organization has released “The Role of Parliaments and Parliamentarians in Strengthening Health Security Preparedness,” an online training course designed to equip parliamentarians with the knowledge and tools necessary to enhance global health security efforts. The COVID-19 pandemic…
In April, at the United Nations Headquarters in New York, governments reaffirmed their commitment to the Programme of Action from the 1994 International Conference on Population and Development (ICPD). The principles of this program are embedded within the United Nations…
Lebrikizumab has been approved for treating moderate-to-severe atopic dermatitis in adolescents (12 years and older) and adults who require systemic therapy. This treatment received approval from the European Commission and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in…
This new addition to the Pixel lineup integrates the company’s semiconductor-to-live-cell interface in an environmental controlled benchtop system to deliver live cell measurements for up to eight 96-well Pixel plates simultaneously. When paired with laboratory robotic automation, the Pixel Octo…
Sinaptica, a clinical-stage company pioneering personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has announced the publication of a study in Alzheimer’s Research & Therapy. The study utilized MRI and fMRI neuroimaging to assess structural and connectivity changes in…
Harrow, a prominent North American eyecare pharmaceutical firm, announced today its agreement with Apexus to include IHEEZO® (chloroprocaine hydrochloride ophthalmic gel) 3% and other key products in the 340B Prime Vendor Program starting July 1, 2024. IHEEZO, designed for ocular…
Adicet Bio, a clinical-stage biotechnology company focused on developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ADI-270. This designation is for…
Country-level preparedness for influenza pandemics is crucial to mitigate global spread and its associated impacts on health and economies. Pandemics can cause widespread illness, high mortality rates, and substantial economic burdens due to healthcare costs and productivity losses. Through coordinated…
Analysis of Recent Influenza Cases The World Health Organization (WHO) has recently issued several Disease Outbreak News reports detailing cases of influenza, highlighting significant developments in detection, sources of exposure, and patient profiles. Here’s a summary of the key findings:…
Global Summit in Kathmandu Advances Efforts Towards Sustainable Sanitation Goals From June 25–27, 2024, delegates representing over 20 countries and various stakeholder organizations convened in Kathmandu for a pivotal Global Sanitation Summit hosted by UNICEF, WHO, and WaterAid. The Summit…
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or “Company”), a clinical-stage biotechnology firm developing advanced targeted virotherapies, has announced that its Board of Directors has approved a 1-for-10 reverse stock split of its outstanding common stock. This Reverse Stock Split…